1. Home
  2. RVPH vs AGFY Comparison

RVPH vs AGFY Comparison

Compare RVPH & AGFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • AGFY
  • Stock Information
  • Founded
  • RVPH 2006
  • AGFY 2016
  • Country
  • RVPH United States
  • AGFY United States
  • Employees
  • RVPH N/A
  • AGFY N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • AGFY Military/Government/Technical
  • Sector
  • RVPH Health Care
  • AGFY Consumer Discretionary
  • Exchange
  • RVPH Nasdaq
  • AGFY Nasdaq
  • Market Cap
  • RVPH 36.7M
  • AGFY 43.6M
  • IPO Year
  • RVPH N/A
  • AGFY 2021
  • Fundamental
  • Price
  • RVPH $0.90
  • AGFY $25.58
  • Analyst Decision
  • RVPH Strong Buy
  • AGFY
  • Analyst Count
  • RVPH 5
  • AGFY 0
  • Target Price
  • RVPH $9.00
  • AGFY N/A
  • AVG Volume (30 Days)
  • RVPH 515.2K
  • AGFY 62.1K
  • Earning Date
  • RVPH 05-15-2025
  • AGFY 05-09-2025
  • Dividend Yield
  • RVPH N/A
  • AGFY N/A
  • EPS Growth
  • RVPH N/A
  • AGFY N/A
  • EPS
  • RVPH N/A
  • AGFY N/A
  • Revenue
  • RVPH N/A
  • AGFY $10,218,000.00
  • Revenue This Year
  • RVPH N/A
  • AGFY N/A
  • Revenue Next Year
  • RVPH N/A
  • AGFY N/A
  • P/E Ratio
  • RVPH N/A
  • AGFY N/A
  • Revenue Growth
  • RVPH N/A
  • AGFY 9.42
  • 52 Week Low
  • RVPH $0.49
  • AGFY $2.71
  • 52 Week High
  • RVPH $4.28
  • AGFY $84.44
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 48.40
  • AGFY 57.67
  • Support Level
  • RVPH $0.85
  • AGFY $27.00
  • Resistance Level
  • RVPH $1.15
  • AGFY $30.09
  • Average True Range (ATR)
  • RVPH 0.11
  • AGFY 2.63
  • MACD
  • RVPH 0.00
  • AGFY 0.05
  • Stochastic Oscillator
  • RVPH 33.28
  • AGFY 73.91

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About AGFY Agrify Corporation

Agrify Corp is a developer of branded inventive solutions for the cannabis and hemp industries. Its Senorita brand offers consumers hemp-derived tetrahydrocannabinol (THC) beverages that mirror cocktails like a margarita - in three flavors - classic Lime Jalapeno Margarita, Mango Margarita, and Paloma. In addition to beverages, Agrify has also historically been a provider of inventive cultivation and extraction solutions for the cannabis industry. Its comprehensive extraction product line, which includes hydrocarbon, alcohol, solventless, post-processing, and lab equipment, empowers producers to maximize the quantity and quality of extract required for premium concentrates.

Share on Social Networks: